Biotin – Glucagon (1 – 29), bovine, human, porcine

Biotin – Glucagon (1 – 29), bovine, human, porcine

Biotin – Glucagon (1 – 29), bovine, human, porcine

Biotin – Glucagon (1 – 29), bovine, human, porcine

Biotin – Glucagon (1 – 29), bovine, human, porcine

Biotin-Glucagon (1-29) is a chemically modified, bioactive peptide where a biotin molecule is covalently conjugated to the N-terminus or a specific lysine residue of the 29-amino acid glucagon peptide. This conjugate preserves the full biological activity of native glucagon while introducing a high-affinity biotin tag. The sequence is identical across bovine, human, and porcine species in the 1-29 region, representing the major active core. 



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Biotin-Glucagon (1-29), bovine, human, porcine
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C163H239N45O51S2
Molecular Weight
3709.12g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (≥ 5 mg/mL), dilute acetic acid, or DMSO; also soluble in phosphate-buffered saline (PBS)

Endotoxin≤1.0 EU/mg
Biological Activity
 Binds to glucagon receptors with high affinity; EC₅₀ typically ≤ 0.5 nM in cAMP accumulation assays using hepatocyte or CHO cell models
Storage Conditions
Store at -20°C to -80°C in a dry, dark environment; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This conjugate functions identically to native glucagon by binding and activating the Glucagon Receptor (GCGR), a Class B G-protein coupled receptor primarily expressed in hepatocytes. Upon binding, the conjugate activates the Gs protein, stimulating adenylate cyclase and dramatically increasing intracellular cyclic AMP (cAMP) levels. This triggers protein kinase A (PKA) activation, leading to the phosphorylation of key enzymes that drive hepatic glycogenolysis and gluconeogenesis, resulting in elevated blood glucose. The covalently attached biotin moiety does not interfere with receptor binding or this signaling cascade. 


    2.PRODUCT INDICATIONS

  • Receptor Localization & Trafficking: Visualizing GCGR distribution and internalization in cells or tissues using streptavidin-conjugated fluorophores for microscopy (IHC, IF, live-cell imaging).

  • Affinity Capture & Proteomics: Isolating glucagon-bound receptors or associated protein complexes from cell lysates using streptavidin-coated beads for mass spectrometry or Western blot analysis.

  • Biosensor & Assay Development: Immobilizing the peptide on streptavidin-coated surfaces (SPR chips, ELISA plates, biosensors) for real-time binding kinetics studies, drug screening, or diagnostic assay development.

  • In SituBinding Studies: Mapping active receptor sites in tissue sections (e.g., liver, pancreas) using biotin-streptavidin detection methods.

  • Quantitative Receptor Analysis: Using the biotin tag for highly sensitive detection in quantitative flow cytometry or other analytical platforms to measure receptor expression levels.

  • High-Throughput Screening (HTS): Serving as a tagged ligand in screening campaigns for GCGR agonists, antagonists, or allosteric modulators.


    3.CLINICAL EFFICACY OF PRODUCT

  • Research Utility: It is highly effective in the applications listed above, providing crucial mechanistic insights into glucagon receptor biology that cannot be obtained with the native peptide alone.

  • Diagnostic Development: The biotin-streptavidin system is foundational to in vitrodiagnostics (IVD). This conjugate can be used to develop research-use-only (RUO) or prototype immunoassays for detecting glucagon receptors or autoantibodies in patient samples.

  • Drug Discovery Support: Research using this tool aids in characterizing novel GCGR-targeting therapeutics (e.g., agonists for hypoglycemia, antagonists for diabetes/NASH) by enabling detailed studies of drug-receptor interactions.

  • No Therapeutic Use: This conjugate is not administered to humans. Clinical efficacy data pertains to the glucagon/GCGR system itself, which is targeted by approved drugs like dasiglucagon (a stable glucagon analog for severe hypoglycemia) and investigational GCGR modulators.


  • 4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.